Mast cells, polymorphonuclear (PMN) 1 leukocytes, monocytes, and macrophages convert arachidonic acid to 5(S), 12(R)-dihydroxy-eicosa-6,14 cis-8,10 trans-tetraenoic acid or leukotriene B4 (LTB4) by 5-1ipoxygenation and subsequent enzymatic hydration of the 5,6-epoxy-eicosatetraenoic acid derived from 5-hydroperoxy-eicosatetraenoic acid (1-5). When platelets are present with the leukocytes, platelet 12-1ipoxygenation of 5-hydroxy-eicosatetraenoic acid (5-HETE) contributes significantly to the generation of LTB4 (4, 6). LTB4 stimulates PMN leukocyte chemotactic and chemokinetic migration (7-11), release of lysosomal enzymes in the presence of cytochalasin B (7, (12) (13) (14) , adherence (15), aggregation (9, 16), expression of CSb receptors (17), and biochemical pathways that are specific prerequisities for the activation of PMN leukocytes (18, 19) . Since the optimal expression of several activities of PMN leukocytes was elicited by different concentrations of LTB4 (7, 13, (15) (16) (17) , it was postulated that either the extent of saturation of a single class of receptors initiated different functions or that a distinct subset of receptors with a different affinity for LTB4 was selectively coupled to each function.
established that the subset of chemotactic receptors for LTB4 is distinct from those that mediate the responses to peptide chemotactic factors (20) . The availability of purified [SH] LTB4 with a specific activity 7-10 times higher than that used in the initial characterization of the LTB4 receptor has now permitted the demonstration of two classes of LTB4 receptors on human PMN leukocytes that differ in affinity for [3H]LTB4 by ~150-fold. A critical functional role is suggested for the high affinity receptors, since they exhibit a Kd similar to the concentration of LTB4 required to evoke a half-maximal PMN leukocyte chemotactic response and are eliminated selectively by chemotactic deactivation of PMN leukocytes to LTB4.
Materials and Methods

Materials.
Hanks' balanced salt solution with phenol red (HBSS) (M. A. Bioproducts, Walkersville, MD), n-butyl phthalate, fatty acid-free bovine serum albumin (BSA), fMLP, phenolphthalein glucuronic acid (Sigma Chemical Co., St. Louis, MO), ovalbumin (OVA) (Miles Laboratories, Inc., Elkhart, IN), [5, 6, 8, 9, 11, 12, 14, 15 (N)-SH]LT B4 (180-221 Ci/ mmol; Amersham Corp., Arlington Heights, IL), Ficoll-Hypaque (6 g/100 ml dextran 70 in normal saline; Pharmacia Fine Chemicals, Piscataway, NJ), dinonyl phthalate (ICN Pharmaceuticals, Inc., Plainview, NY), cytochalasin B (Aldrich Chemical Co., Milwaukee, WI), and Hydrofluor (National Diagnostics, Inc., Somerville, NJ) were obtained from the suppliers noted. All organic solvents were redistilled from glass (HPLC grade; Burdick & Jackson Laboratories, Inc., Muskegon, MI). Partially purified chemotactic fragments of C5 (C5fr) were prepared from yeast-activated human serum as described (7, 10) . Synthetic LTD4 (5-hydroxy-6-S-cysteinyl-glycyl-eicosatetraenoic acid), LTB4, and 12(S)-LTB4 were kindly supplied by Dr. J. Rokach of Merck-Frosst Laboratories, Dorval, Canada. 5-HETE and the 5(S), 12(S)-isomer of 6 trans-LTB4 [5(S), 12(S)-6 trans-di-HETE] were biosynthetically prepared and purified by reverse-phase high performance liquid chromatography (HPLC) as described (20) .
Preparation of Human PMN Leukocytes. Human PMN leukocytes were prepared as described (22) from sodium citrate-anticoagulated venous blood of normal donors. Erythrocytes were removed by dextran sedimentation followed by a 20-s hypotonic lysis with 20 vol of ice-cold distilled water. Isotonicity was restored by adding 0.6 M KCl. PMN leukocytes of 96% or greater purity were obtained by centrifugation of mixed leukocytes on FicolI-Hypaque cushions (23) . The purified PMN leukocytes were suspended at concentrations of up to 5 x 107 per ml in HBSS containing 0.1 g/100 mi OVA and 10 mM Hepes (pH 7.3) (HBSS-OVA), stored at 4°C, and used within 1-2 h. LTB4 and nonradiocative fatty acids were reduced nearly to dryness in separate glass tubes under nitrogen and taken up in HBSS-OVA at 4°C, immediately before use as described (20) . In each experiment, 5 + 3 x 10 -14 tool (mean -+ range) of [SH]LTB4 and different concentrations of each nonradioactive fatty acid were incubated with replicate suspensions of 2 x 106 or 1 x 10 7 PMN leukocytes in a final volume of 0.5 ml for 40 min in an ice water bath. The amount of radioactivity bound to the PMN leukocytes was determined by layering each suspension on 0.3 ml of a mixture of n-butyl phthalate and dinonyl phthalate (7:2, vol/vol) in a 1.5-ml polypropylene tube and centrifuging for 30 s at 8,000 g in a Beckman microfuge B (Beckman Instruments, Inc., Fullerton, CA). The tip of each polypropylene tube containing the PMN leukocyte pellet was cut off with a razor blade, the contents of the tip were resuspended with a Pasteur pipette in 4 ml of Hydrofluor, and the amount of radioactivity in the pellet and 0.1 ml of the upper aqueous layer was determined separately.
Measurement of the Binding of [SH]LTB4 to PMN Leukocytes. Methanol solutions of [3H]-
In a few experiments, [aH]LTB4 was incubated with 2 x 107 PMN leukocytes in 1 ml of HBSS-OVA for 60 min on ice. The suspensions then were acidified to pH 3.5 with glacial acetic acid, 1 vol of isopropanol was added, and the suspension was extracted twice with 1 vol of ethyl ether and once with 1 vol of chloroform. The organic layers were pooled and dried under a stream of nitrogen, and the extracted lipids were redissolved in chromatography solvent for analysis.
HPLC. LTB4, other 5,12-di-HETE isomers, and 5-HETE were resolved by reversephase HPLC on a 4.6-mm × 25-cm column of 10 t~m octadecyl(C 18)-silane (Ultrasil; Altex Scientific Inc., Berkeley, CA) that was developed isocratically at a flow rate of 1.7 ml/ rain with methanol/water/acetic acid (70:30:0.03, vol/vol, titrated to pH 4.5 with ammonium hydroxide) (3). Analysis of the stock solutions of [SH]LTB4 revealed that 99% of the radioactivity cochromatographed with a synthetic LTB4 standard and the remaining 1% eluted at several earlier times. The purified and synthetic 5,12-di-HETE isomers and 5-HETE contained <3% optically determined impurities. The [SH]LTB4 also was converted to the methyl ester and subjected to standard-phase HPLC on a uPorasil column (Waters Associates, Milford, MA) that was developed isocratically with hexane/2-propanol (91:9, vol/vol) at 1.3 ml/min and again was shown to contain <1% radiochemical contamination. In three separate studies, 97.2 _+ 2.4% (mean _ 2 SD) of the [3H]LTB4 was bound by specific rabbit anti-LTB4 serum and >98% was displaced by synthetic LTB4 (3).
Analysis of Binding Data. The specific activity of the [3H]LTB4 in each incubation tube was determined by dividing the total cpm recovered from the cell pellet and the aqueous layer by the total number of moles of LTB4 present in the incubation tube. The cpm bound to the PMN leukocytes divided by the specific activity and the total volume of the incubation suspension equaled the concentration of bound LTB4. The concentration of free LTB4 was determined by dividing the cpm in the aqueous layer by the specific activity. The binding data were fit by a method of weighted nonlinear least squares to the ligand-binding model developed by Feldman (24) using a Wang 2200 series computer (Wang Laboratories, Inc., North Chelmsford, MA). The curve-fitting program is based on the LIGAND program described by Munson and Rodbard (25) and uses the NewtonGauss-Marquardt-Levenberg algorithm as described by Fletcher and Schrager (26) to find those values for each parameter which minimized the weighted sum of the squares. The variance for the bound LTB4 was determined to be 5% of the concentration of bound LTB4 across the range of free LTB4 concentrations tested. The ~extra sum of squares" test (F statistic) (25) was used to compare the aptness of fit to models of one and two classes of receptors. Nonspecific binding was estimated by the curve-fitting program and was subtracted from the total binding data to yield the specific binding data. Analysis of the data collected for inhibition of [3H]LTB4 binding by LTB4 analogs was performed using the curve-fitting program by setting the association constants for LTB4 binding equal to the values previously determined in the absence of a competitive ligand and then calculating nonspecific binding, the total concentration of the high and low affinity receptors, and the association constants of the competing ligand for each of the receptors.
Deactivation of Human PMN Leukocyte Chemotaxis. Replicate suspensions of 1 x 107
PMN leukocytes/ml of HBSS-OVA were incubated with a range of concentrations of LTB4 or buffer alone (control PMN leukocytes) for 10 rain at 37°C. At the end of the incubation, 5 vol of ice-cold HBSS containing 0.2 g/100 ml fatty acid-free BSA (HBSS-BSA) were added to each suspension of PMN ieukocytes. The PMN leukocytes were washed twice with HBSS-BSA and three times with HBSS at 4°C. The LTB4-treated PMN leukocytes were suspended at 2 × 107 per ml of HBSS-OVA on ice. The total and nonspecific binding of [3H]LTB4 was determined by incubating 4 x 10 B PMN leukocytes with 1 × 10 -1° M [SH]LTB4 in 0.5 ml HBSS-OVA in the absence and presence of 1.5 uM LTB4, which displaced 88.4 ± 3.6% (mean ± SD, n = 7) of the total binding. Subtracting the nonspecifically bound radioactivity from the total bound radioactivity gave the specific binding component. The amount of radioactivity specifically bound to control PMN leukocytes pretreated at 37°C in HBSS-OVA alone was defined as 100%.
The chemotaxis and lysosomal enzyme release of PMN leukocytes preincubated with LTB4 or in buffer alone (controls) were assessed in parallel with the binding of [aH]LTB4. Chemotaxis was performed in modified Boyden chambers (Adaps, Inc., Dedham, MA) assembled with micropore filters of 3 #m pore diameter (Sartorius, Bottingen, Federal Republic of Germany) (22, 27) . PMN ieukocytes were enumerated microscopically in 10 high power fields (hpf), 5 from each of duplicate filters, at a depth of 80-100 t~m from the cell source. The depth for counting was selected to achieve a background count of three to six PMN leukocytes per hpf. The response is expressed as net PMN ieukocytes per hpf, after subtraction of background migration in control chambers lacking a stimulus. The altered chemotactic migration of PMN leukocytes pretreated with LTB4 is expressed as a percentage of the migration of replicate portions of PMN leukocytes preincubated in HBSS-OVA alone.
The stimulation of release of B-glucuronidase from lysosomal granules was determined by incubating replicate suspensions of 2 x 10 ~ PMN leukocytes in 0.4 ml of HBSS-OVA containing the stimulus or buffer alone and 5 t~g/ml of cytochalasin B at 37°C for 30 min. Each supernate was assayed colorimetrically for B-glucuronidase activity as described (7) . The amount of release of/3-glucuronidase is expressed as a percentage of the total amount of activity present in replicate suspensions of PMN ieukocytes that had been disrupted by sonication on ice. The percentage of O-glucuronidase released in the absence of a stimulus was subtracted to determine the net percentage release. The altered release of/3-glucuronidase by PMN ieukocytes pretreated with LTB, is denoted as a percentage of the release by PMN leukocytes preincubated in HBSS-OVA alone.
The statistical significance of binding parameters for deactivated PMN leukocytes relative to the binding parameters for untreated PMN leukocytes was determined by a standard t test for unpaired populations of samples with unequal variance. The statistical significance of the results of studies of the function of deactivated PMN leukocytes relative to the data for controls was determined by a standard two-sample t test for paired samples. (Fig. 1) . When 1.5 #M nonradioactive LTB4 was added to PMN leukocytes that had been incubated with [~H]LTB4 for 45 min at 0°C, 77.7 _ 4.8% (mean 4-SD, n = 3) of the specifically bound [3H]LTB4 was dissociated within 10 min after the addition of the LTB4 and the remainder was dissociated at a slower rate (Fig. 1) . By 105 min after the addition of 1.5 #M LTB4, 89.6 + 2.0% of the specifically bound [3H]LTB4 had been released from the PMN leukocytes.
Results
Characteristics of the Binding of [3H]LTB4 by
The rapid association and dissociation of the bulk of the [3H]LTB4 specifically bound to PMN leukocytes suggested that the system was at equilibrium in the standard binding studies and that equilibrium binding parameters could be derived accurately. The total amount of LTB4 bound to PMN leukocytes was a function of the free concentration of LTB4 (Fig. 2 A) . Whereas total and nonspecific binding increased with the concentration of LTB4 up to 1,600 nM, specific binding was saturated at LTB4 concentrations of 800 nM and greater. The specific binding of LTB4 at 1,600 nM was 108 4-23% (mean 4-SD, n = 5) of the specific binding at 800 nM. Computer analysis of the concentration dependence of total binding ( Fig. 2A) revealed that the data were best fit (P < 0.01) by a model consisting of two different classes of binding sites for LTB4 and a nonspecific binding component. The biphasic nature of the Scatchard plot of the values for specific binding of LTB4 (Fig. 2B) supported the suitability of a model of two classes of receptors for the binding of LTB4 to PMN leukocytes. The high affinity and low affinity binding sites had mean Kd values of 3.9 X 10 -1° M and 6.1 x 10 -8 M, respectively, for LTB4 (Table I ). There were 4.4 4-1.2 x l0 s high affinity receptors (mean 4-SD) and 2.7 4-1.8 x 105 low affinity receptors per PMN leukocyte.
Structural Determinants of the Binding of [3H]LTB4 to PMN Leukocytes. The inhibition of binding of [3H]LTB4
to PMN leukocytes by chemotactically less potent 5,12 di-HETE isomers was assessed in parallel with studies of chemotactic activity ( Fig. 3 and Table I ). Both of the other 5,12 di-HETE isomers inhibited by up to 100% the specific binding of [3H]LTB4 to PMN leukocytes. Further, the concentrations at which the isomers inhibited by 50% the binding of [3H]-LTB4 (ICs0 values) were in the same relative rank order as the concentrations required to achieve 50% of the maximal chemotactic response (EC~0) (Fig. 3 and Table I 3.9 ± 2.4 x 10 -I° 6.1 ± 2.9 x 10 -8 3.0 x 10 -9 12(S)-LTB4 2.2 ± 0.4 x 10 -9 2.0 ± 1.6 x 10 -~ 6.3 x 10 -8 5(S),12(S)-6 trans-di-HETE 5.8 ± 2.7 X 10 -8 --0.8-1.0 X 10 -6 * The dissociation constants were determined by fitting the binding data to one-and two-site binding models using a nonlinear least squares curve-fitting program. The binding data were best fit by a two-site model for LTB4 and 12(S)-LTB4 (P < 0.001) and by a one-site model for the 5(S),12(S)-6
trans-di-HETE, which yielded a single Kd.
* The ECs0 values for the stimulation of human PMN leukocyte chemotaxis by LTB4 and 5(S), 12(S)-
6 trans-di-HETE had been previously determined (10, 11) , while that for 12(S)-LTB4 was derived from results of three current studies, where the mean + SD was 6.3 ± 2.9 × 10 -s M. 
FIGURE 3. Inhibition of the specific binding of [SH]LTB4 by unlabeled LTB4 (D), 12(S)-LTB4 (&), 5(S),12(S)-6 trans-di-HETE (ZX), LTD4 {O), and 5-HETE (O)
. Each data point represents the mean _. SD of duplicate measurements from three experiments. The inhibitory dissociation constants for the three isomers of 5,12-di-HETE are summarized in Table I. suggest that LTB4 and 12(S)-LTB4 each bind with markedly different affinities to the two classes of sites, whereas 5(S), 12(S)-6 trans-di-HETE exhibited approximately the same affinity for the two types of LTB4 binding sites. These conclusions were confirmed by a nonlinear least squares analysis of the data (Fig. 3) , which yielded characteristic inhibitory dissociation constants for LTB4 and the other isomers of 5,12-di-HETE ( 
Correlation of the Reduction in [~H]LTB4 Binding with the Decrease in Chemotactic
Response of Deactivated PMN Leukocytes. Preincubation of PMN leukocytes with LTB4, followed by washing, resulted in a decreased chemotactic response to LTB4, whereas the chemotactic response to other stimuli was only minimally decreased (27) . A similarly selective decrease in the chemotactic responsiveness ofPMN leukocytes pretreated with N-formyi-methionyl peptides has been termed deactivation and shown to correlate with a decrease in the number of PMN leukocyte receptors for N-formyl-methionyl peptides (28, 29) . PMN leukocytes pretreated at 37°C for 10 min with different concentrations of LTB4 exhibited significantly diminished chemotactic responses to subsequent stimulation with LTB4 (Fig. 4A) . The chemotactic responses to 3 × 10 -9 M and 3 × 10 -s M LTB4 were suppressed significantly by preincubation of PMN leukocytes with concentrations of LTB4 as low as 0.1 and 0.3 nM, respectively. The amount of [3H]-LTB4 bound to the PMN leukocytes decreased concomitantly with the chemotactic response. The chemotactic response to C5fr also decreased in a conentration-dependent manner after pretreatment of the PMN leukocytes with LTB4, but a 30-100-fold higher LTB4 concentration was required to achieve the same extent of deactivation to C5fr as to 3 × 10 -s M LTB4. With preincubation concentrations of 3 × 10 -2° M LTB4 or higher, the chemotactic response to C5fr was significantly greater (P < 0.05, paired Student's t test) than that to 3 × 10 -8 M LTB4.
Scatchard analysis of the binding of [3H]LTB4 to PMN leukocytes pretreated with 1 × 10 -8 M LTB4 revealed a complete loss of the high affinity receptors along with a significant change in the number and affinity of the low affinity receptor for LTB4 (Fig. 5) . The PMN leukocytes pretreated with LTB4 exhibited a single class of LTB4 receptors with a Kd of 3.1 + 2.8 X 10 -7 M (mean ___ SD, n = 3) and a receptor density of 1.1 + 1.0 × 106 per PMN leukocyte. The receptors expressed on the LTB4-deactivated PMN leukocytes exhibited a significantly lower affinity (P -0.04) and higher density (P = 0.05) than those observed on untreated PMN leukocytes using a Student's t test for unpaired populations of samples. Preincubation of PMN leukocytes with HBSS-OVA alone at 37 °C did not alter the binding of [3H]LTB4 (Fig. 5) .
The selective loss of the high affinity receptors for LTB4 and the parallel reduction in chemotactic responses to LTB4 after deactivation suggested that the high affinity receptors may mediate the chemotactic responses of PMN i I O0----- A paired Student's t test was used to assess the statistical significance of differences between control leukocytes and LTB,-treated leukocytes; levels of significance are as follows: *, P < 0.05; +, P < 0.01; ++, P < 0.005. leukocytes to LTB4. The elicitation of release of granule enzymes in the presence of cytochalasin B requires significantly higher concentrations of LTB4 than chemotaxis and thus was considered to be mediated by the low affinity receptors for LTB4. Pretreatment of PMN leukocytes with 1 × 10 -s M LTB4 at concentrations that inhibited completely the chemotactic response to LTB4 did not significantly inhibit the release of/3-glucuronidase evoked by 3 × 10 -7 M LTB4 and only minimally suppressed that elicited by 3 × 10 -s M LTB4 (Fig. 4B) . That none of the high affinity receptors were expressed on chemotactically deactivated PMN leukocytes implies that LTB4 stimulates enzyme release principally by binding to the low affinity PMN leukocyte receptors for LTB4.
Discussion
The availability of [3H]LTB4 of high specific activity and purity and the application of computer-based least squares fitting of the results of binding to PMN leukocytes permitted the definition of two classes of receptors of different affinities. The specific binding of [SH]LTB4 to PMN leukocytes accounted for >88% of the total binding at equilibrium, as assessed by the extent of inhibition of binding by a 15,000-fold higher concentration of nonradioactive LTB4. Maximum specific binding of [SH]LTB4 was attained rapidly, reaching a plateau level within 10 min, and was rapidly dissociated by the addition of a 15,000-fold higher concentration of nonradioactive LTB4 (Fig. 1) . The specific binding of LTB4 was concentration dependent and reached saturation at 800 nM LTB4. Analysis of the curvilinear Scatchard plot of the LTB4 binding data indicated that the best fit was achieved by a model of two classes of receptors of different affinities (Fig. 2) . The two classes of LTB4 receptors consisted of a mean of 4.4 × l0 s and 2.7 × 105 sites per PMN leukocyte with respective mean affinities of 3.9 × 10 -1° M (Kal) and 6.1 x 10 -8 M (Kd2) ( Table I) .
The coupling of the high affinity receptors for LTB4 to the stimulation of PMN leukocyte chemotaxis was suggested initially by the similarity of the Ka~ for LTB4 and the concentration of LTB4 required to elicit a chemotactic response that was 50% of maximum (ECs0) ( Table I) . This relationship was confirmed by the results of studies of chemotactic structural isomers of LTB4 (Fig. 3 , Table I ). 12(S)-LTB4 is a chemotactic factor for PMN leukocytes that possessed only 5% of the potency of LTB4 and exhibited a Ka~ -5.5-fold greater than that of LTB4. The 5(S),12(S)-6 trans-di-HETE had only 1/100th the chemotactic potency of LTB4 and had a Kal -150-fold greater than that of LTB4. The Kdl for 5(S), 12(S)-6 trans-di-HETE was indistinguishable from the Ka2, indicating that unlike LTB4 and 12(S)-LTB4, it binds with equal affinity to the two classes of LTB4 receptors.
The results of binding and functional studies of PMN leukocytes deactivated chemotactically by preincubation with LTB4 and washing confirmed the importance of high affinity receptors in the transduction of chemotaxis. A fully deactivating exposure to LTB4 reduced by >80% the specific binding of [SH]-LTB4 (Fig. 4) , which was attributable predominantly to loss of binding by the high affinity receptors (Fig. 5) . The extent of loss of high affinity binding of [SH]-LTB4 with prior exposure to different concentrations of LTB4 correlated with the degree of reduction in chemotactic response to LTB4, whereas the lysosomal degranulating effect of a low concentration of LTB4 was diminished only minimally and that of a high concentration of LTB4 was unchanged (Fig. 4) .
Several theoretical models have been proposed to account for the upwardly concave curvilinear Scatchard plots seen in studies of other receptors, including fixed heterogeneity of combining sites, negatively cooperative site-site interactions, multi-step binding reactions to distinct components of a single class of receptors, and competition of an unlabeled ligand for the nonspecific binding component. The latter possibility is unlikely because three structurally distinct chemotactic isomers of 5,12-di-HETE all suppressed the binding of [SH]LTB4 to the same level of nonspecific binding. The remaining models for curvilinear Scatchard plots cannot be differentiated on the basis of equilibrium binding data alone, but require further information on the kinetics of ligand binding, on the structure of the binding sites, and on the possible association of the binding sites with other putative effector molecules of the PMN leukocytes.
We have chosen to interpret the binding of LTB4 to PMN leukocytes in terms of two independent classes of binding sites because of the evidence relating high affinity binding sites to the chemotactic responses of PMN leukocytes to LTB4.
The possible relationship between the low affinity binding site and the stimulation by LTB4 of lysosomal enzyme release is not proven, but is suggested both by the similarity of Ka2 and the concentrations of LTB4 required to achieve ~3-glucuronidase release and by the failure of chemotactic deactivation to suppress either the expression of the low affinity binding sites or PMN leukocyte enzyme release in response to LTB4.
Other support for the functional role of high affinity LTB4 receptors is derived from the results of studies of the expression of PMN leukocyte receptors for fMLP. Chemotaxis is elicited by low concentrations and lysosomal enzyme secretion by higher concentrations of fMLP (31, 32) . Human PMN leukocyte receptors for fMLP in isolated membrane preparations exist in both high and low affinity states, that are in part interconvertible through a mechanism regulated by guanine nucleotides (33) . Aiiphatic alcohols (34) and polyene antibiotics (35) influence the affinity state of the fMLP receptors on intact PMN leukocytes and the effects of such agents have supported a relationship of high affinity receptors to chemotaxis and of low affinity receptors to lysosomal enzyme secretion. For example, the shift from low to high affinity sites induced by the aliphatic alcohols enhances chemotaxis and suppresses enzyme secretion, while the opposite effect of polyene antibiotics on receptor affinity diminishes chemotaxis and enhances enzyme secretion. While such studies have not been performed for LTB4 receptors, intact human PMN leukocytes before any manipulation have two clearly definable classes of receptors for LTB4 (Fig. 2, Table I ), but not for fMLP (32) . Nonetheless the net effective expression of the high affinity receptors for LTB4 may be attributable to complex cellular mechanisms, as chemotactic deactivation alters rapidly and strikingly the affinity and/or number of such receptors (Fig. 5) . The relationship of alterations in the high affinity receptors for LTB4 to chemotactic defects induced in vitro and acquired in some human diseases is now susceptible to analysis and may provide new approaches for correcting such functional defects. to PMN leukocytes at concentrations similar to those required to elicit chemotaxis, while chemotactic peptides did not inhibit binding. PMN leukocytes that were deactivated by prior exposure to LTB4 lost high affinity binding sites selectively and concurrently with a reduction in the chemotactic response to LTB4. Chemotactic deactivation altered, but did not eliminate, the low affinity receptors for LTB4 and reduced only minimally the lysosomal degranulation elicited by LTB4. The high affinity receptors for LTB4 on normal human PMN leukocytes appear to transduce the chemotaxis evoked by LTB4 without substantially modifying lysosomal degranulation.
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